Healthcare -
Biotechnology - NASDAQ - US
$ 36.91
0.819 %
$ 3.49 B
Market Cap
-6.33
P/E
RARE - DEFERRED INCOME TAX
Deferred Income Tax RARE - Ultragenyx Pharmaceutical Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR